Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents

Recruiting

Observational StudyReal-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents

Sponsor:

Neurocrine Biosciences

Code:

NCT03062033

Conditions

Tardive Dyskinesia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-08-25. This information was provided to ClinicalTrials.gov by Neurocrine Biosciences on 2017-11-22.